http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134238fb2310afac680a2b8fabbc6cf4
Outgoing Links
Predicate | Object |
---|---|
family-name | Levine |
name | Mark. Levine Mark Levine |
given-name | Mark Mark. |
organization-name | Departments of Surgery, Clinical Epidemiology and Biostatistics, and Medicine, Faculty of Health Sciences, McMaster University; Juravinski Cancer Centre, Hamilton, Ontario, Canada National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; From the Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton; Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto; and Ministry of Health and Long-Term Care, Toronto, Ontario, Canada. From the Division and Program in Human Genetics (H.D., G.A.G.) and Division of Pathology and Laboratory Medicine (D.P.W.), Children’s Hospital Research Foundation, Cincinnati, OH, 45229; and Genzyme Corporation (S.S., N.W., M.L.), Cambridge, MA. From the National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada. Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Radiation Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Free Radical and Radiation Biology Program, University of Iowa, Iowa City, IA 52242-1101; and Laboratory of Biochemistry, Center for Drug Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892 From the McMaster University, Hamilton; University of Toronto, Toronto; University of British Columbia, Vancouver; Northeastern Ontario Regional Cancer Centre, Sudbury; and Queen's University, Kingston, Canada Molecular and Clinical Nutrition Sections, Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892 Ontario Clinical Oncology Group Hamilton Ontario Canada; Department of Health Research Methods, Evidence and Impact McMaster University Hamilton Ontario Canada; Department of Oncology McMaster University Hamilton Ontario Canada Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada. Ontario Clinical Oncology Group McMaster University Hamilton Ontario Canada; Department of Oncology McMaster University Hamilton Ontario Canada Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1372; and Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602 National Institutes of Health, Washington, DC, USA From McMaster University; Ontario Clinical Oncology Group; and Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada Department of Medicine, McMaster University, Hamilton, Ontario, Canada. mlevine@mcmaster.ca Sanofi Biotherapeutics Framingham Massachusetts USA National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; and Lancaster University, Department of Psychology, University of Exeter, Exeter, UK Gary H. Lyman, Duke University and the Duke Cancer Institute, Durham, NC; and Mark Levine, McMaster University, Hamilton, Ontario, Canada. Annie M. Young, Andrea Marshall, Jenny Thirlwall, Catherine Hill, Danielle Hale, Janet A. Dunn, and Stavros Petrou, Warwick Clinical Trials Unit, University of Warwick; Oliver Chapman and Christopher J. Poole, University Hospitals Coventry and Warwickshire; Charles Hutchinson and Jeremy Dale, Warwick Medical School, University of Warwick, Coventry; Anand Lokare, Heart of England National Health Service Foundation Trust, Birmingham; Peter MacCallum, Queen Mary University of London; Ajay Kakkar, Thrombosis... Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada; Department of Anesthesiology and Pain Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada 9Molecular and Clinical Nutrition Section, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland. Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1372, MarkL@intra.niddk.nih.gov Molecular and Clinical Nutrition Section, Building 10, Room 4D52, MSC 1372, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda MD 20892-1372; Departments of Medicine and Microbiology and Center for Microbial Pathogenesis, Biomedical Research Building Room 141, State University of New York, 3435 Main Street, Buffalo, NY 14215; and Pediatric Oncology Branch, National Cancer Institute, Building 10, Room 13N240, National Institutes of Health,... Department of Oncology, McMaster University, Hamilton, ON, Canada; Escarpment Cancer Research Institute, Hamilton, ON, Canada; Ontario Clinical Oncology Group, McMaster University, Hamilton, ON, Canada National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Molecular and Clinical Nutrition Section, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, Maryland Juravinski Cancer Center, Hamilton Health Science, Hamilton, Ontario, Canada; Department of Oncology, McMaster University, Hamilton, Ontario, Canada; Ontario Clinical Oncology Group, Hamilton, Ontario, Canada University of Exeter UK; Lancaster University UK Escarpment Cancer Research Institute, Hamilton, Ontario, Canada Lancaster University, United Kingdom University of Exeter, UK Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada; Ontario Clinical Oncology Group McMaster University Hamilton Ontario Canada; Department of Oncology McMaster University Hamilton Ontario Canada From the National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; James C. Wade, Geisinger Cancer Institute, Danville, PA; Dawn Camp-Sorrell, University of Alabama, Birmingham, AL; Diane G. Cope, Florida Cancer Specialists and Research Institute, Fort Myers, FL; Bassel F. El-Rayes, Emory University, Atlanta, GA; Mark Gorman, Patient Representative, Silver Spring, MD; Jennifer Ligibel, Dana-Farber... Molecular and Clinical Nutrition Section, Digestive Disease Branch, Intramural Research Program, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD *Molecular and Clinical Nutrition Section and Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada University of Lancaster, England Ontario Clinical Oncology Group, Juravinski Hospital and Cancer Center, McMaster University, Hamilton, Ontario, Canada Molecular and Clinical Nutrition Section Digestive Diseases Branch Intramural Research Program National Institute of Diabetes Digestive and Kidney Diseases National Institutes of Health Bethesda Maryland USA McMaster University, Hamilton, Ontario, Canada Lowell, Massachusetts, NIDDK, NIH, Bethesda, Maryland Molecular and Clinical Nutrition Section, Digestive Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Authors' Affiliations: Departments of 1Surgery, 2Radiation Oncology, and 3Pathology, University of Iowa College of Medicine; 4Holden Comprehensive Cancer Center and 5Veterans Affairs Medical Center, Iowa City, Iowa; and 6Molecular and Clinical Nutrition Section, Digestive Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland From the National Institute of Diabetes and Digestive and Kidney Diseases, the National Cancer Institute, and the Clinical Center, National Institutes of Health, Bethesda, Maryland; the Food and Drug Administration, Rockville, Maryland; and Bio-Communications Research Institute, Wichita, Kansas. Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, and the Juravinski Cancer Centre, Hamilton, Ontario, Canada Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada L8S 4L8 Ontario Clinical Oncology Group, Hamilton, Ontario, Canada Ontario Clinical Oncology Group, McMaster University Hamilton Ontario; Department of Oncology McMaster University Hamilton Ontario From the Supportive Cancer Care Research Unit and Departments of Medicine, Clinical Epidemiology and Biostatistics, and Surgery, McMaster University, Hamilton; Hamilton Regional Cancer Centre, Hamilton; Henderson Division, Hamilton Health Sciences Corporation, Hamilton; Ottawa Civic Hospital, Ottawa; Brantford General Hospital, Brantford; Department of Surgery, University of Toronto, Toronto; St. Catharines General Hospital, St. Catharines; and Guelph General Hospital, Guelph, Ontario, Canada. Department of Psychology, University of Exeter Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Molecular and Clinical Nutrition Section; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Bethesda 20892 Maryland Vermont Department of Health, Burlington, Vermont (M.L.) Molecular and Clinical Nutrition SectionNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of Health Bethesda Maryland Lancaster University Vermont Department of Health. Pamela J. Goodwin, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Center; Pamela J. Goodwin and Kathleen I. Pritchard, University of Toronto, Toronto; Roanne J. Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa; Gregory R. Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center; Brian Findlay, Niagara Health System, Walker Family Cancer Center; Gregory R. Pond, Mark... Affiliations of authors: Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD (DX, LR); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (ML); Memorial Sloan Kettering Cancer Center, New York, NY (TB, JM); University of Kansas, Lawrence, KS (QC); University of Florida, Gainsville, FL (SC); Yale University, New Haven, CT (YCC); U National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 20892 Department of Clinical Epidemiology and Biostatistics, McMaster University and the Hamilton Regional Cancer Center, Hamilton, Ontario, Canada Molecular and Clinical Nutrition Section, Digestive Diseases Branch, Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, Maryland , USA |
Incoming Links
Total number of triples: 319.